Taysha Gene Therapies (TSHA) Non Operating Income (2020 - 2026)
Taysha Gene Therapies (TSHA) posted Non Operating Income of $710,000 for Q2 2026, compared with -$129,000 a year earlier and down 34.0% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Non Operating Income (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at Taysha Gene Therapies was $3.53 million, up 174.6% year-over-year; for FY2025, it came in at $1.5 million, down 30.4% from FY2024.
- In prior years, Taysha Gene Therapies' Non Operating Income was $2.16 million in FY2024, -$39.13 million in FY2023, -$3.57 million in FY2022 and -$1.26 million in FY2021.
- Quarterly Non Operating Income has run from a low of -$100.84 million in Q3 2023 to a high of $63.99 million in Q4 2023 over five years.
- According to Business Quant data, Non Operating Income for the three prior quarters was $1.08 million (Q1 2026), $449,000 (Q4 2025) and $1.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Taysha Gene Therapies | 1.58 Bn | 1.58 Bn | - | 710,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 710,000.00 |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 449,000.00 |
| Sep 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | -129,000.00 |
| Mar 31, 2025 | -108,000.00 |
| Dec 31, 2024 | 1.15 Mn |
| Sep 30, 2024 | 374,000.00 |
| Jun 30, 2024 | 371,000.00 |
| Mar 31, 2024 | 269,000.00 |
| Dec 31, 2023 | 63.99 Mn |
| Sep 30, 2023 | -100.84 Mn |
| Jun 30, 2023 | -1.21 Mn |
| Mar 31, 2023 | -1.06 Mn |
| Dec 31, 2022 | -1.11 Mn |
| Sep 30, 2022 | -1.07 Mn |
| Jun 30, 2022 | -719,000.00 |
| Mar 31, 2022 | -666,000.00 |
| Dec 31, 2021 | -662,000.00 |
| Sep 30, 2021 | -506,000.00 |
API Access
Taysha Gene Therapies Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();